Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, updated its long-term financial targets and plans to provide additional detail at its ...
A critical vulnerability in the popular expr-eval JavaScript library, with over 800,000 weekly downloads on NPM, can be exploited to execute code remotely through maliciously crafted input. The ...
Google is rolling out out a new feature for Gemini's Canvas, the free interactive workspace inside the AI chatbot's app, meant for students and employees who need to create presentations. Gemini is ...
Oracle sees total revenue growing to $225 billion in fiscal 2030 Adjusted profit seen at $21 per share in 2030 vs $18.92 LSEG estimate Expects adjusted gross margins of 30-40% in AI cloud computing ...
Production and Financial Projections (FY 2026-2030) Petra’s five-year guidance shows total diamond production is expected to increase from 2.4-2.8 million carats in FY 2026 to peak at 3.0-3.5 million ...
As the henchmen of the National Sports Commission(NSC) made an advanced presentation to the Commonwealth Games Federation (CGF) in London, President Bola Ahmed Tinubu has yet again reiterated that ...
The breach hit core JavaScript libraries such as chalk and strip-ansi, downloaded billions of times each week, raising alarms over the security of open-source software. Hackers have compromised widely ...
At least 18 popular JavaScript code packages that are collectively downloaded more than two billion times each week were briefly compromised with malicious software today, after a developer involved ...
In context: Windows has included a proprietary JavaScript engine since the release of Internet Explorer 3.0 nearly 30 years ago. Technically, JScript is Microsoft's own dialect of the ...
Are you a student who is struggling to convince your parents to buy you a Mac for college? Apple has come up with a humorous solution for you. Apple today shared The Parent Presentation, which ...
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with ...